Review
From the reviews:
"Malignant Mesothelioma is an uncommon neoplasm usually associated with exposure to asbestos. a ] Harvey Pass and colleagues have edited an up-to-date, comprehensive book that includes a wide range of information, from a historical perspective to descriptions of the latest treatment. a ] Laboratory researchers will use it as a resource for information a ] of mesothelioma. a ] Clinicians will benefit from this complete guide ... . I highly recommend this book to all those who are interested in mesothelioma." (Julie R. Brahmer, The New England Journal of Medicine, March, 2006)
"This is a reference book suitable for departmental and medical libraries and for the shelves of those who have a particular clinical or research interest in mesothelioma a ] . Pass, Vogelzang and Carbone envisioned a comprehensive text and have achieved it. a ] To be useful such a book must be well indexed; and this is. The individual chapters are well referenced a ] . The text is well edited a ] . This is a quality production. a ] Overall it is highly recommended." (Michael Byrne, CancerForum, Vol. 30 (3), November, 2006)
Product Description
Malignant mesothelioma is a rare form of cancer in which the cancer cells are found in the sac lining the chest (pleura) or abdomen (peritoneum). This lethal disease is associated with asbestos and has vast economic and legal implications. As the disease takes approximately twenty years to manifest itself in humans, a wave of diagnoses are expected in the near future. In the United States alone, an estimated 3,500 - 4,000 patients are diagnosed with mesothelioma annually, and it is estimated that over the next 35 years, more than 250,000 people in Western Europe will be diagnosed with the disease. Malignant Mesothelioma, edited by internationally recognized experts in the field, is a comprehensive text that relates science, pathology, clinical aspects and therapy for mesothelioma under one cover. The book integrates the newest research and advances in its discussions of the disease, covering such topics as carcinogenesis, epidemiology, benchwork, endoscopy, multimodality approaches and treatment. It includes discussions on novel approaches to mesothelioma, such as gene therapy, vaccination strategies and immunotherapy, as well as discussions on the legal and economic aspects of the disease. Over 200 illustrations round out the text. An invaluable reference for the medical oncologist, thoracic surgeon, radiation oncologist, pulmonologist, and benchworker interested in the disease.